| |
| |
|
| Insider
Information: |
Michel Gerard J |
| Relationship: |
|
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
601,280 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15,873,352 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
601,280 |
|
|
| Total
Value |
$15,873,352 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
10
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
7
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -15.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NPS Pharmaceuticals Inc |
NPSP |
CFO & VP |
2004-02-02 |
937 |
2004-02-02 |
0 |
Premium* |
|
|
Albireo Pharma Inc |
ALBO |
CFO, VP of Corp and De... |
2014-03-12 |
43,810 |
2011-02-08 |
0 |
Premium* |
|
|
Vericel Corp |
VCEL |
|
2020-04-01 |
253,865 |
2014-09-16 |
0 |
Premium* |
|
|
Delcath Systems Inc |
DCTH |
|
2024-03-19 |
302,668 |
2020-12-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NPSP |
NPS Pharmaceuticals Inc |
CFO & VP, Corp. Development |
• – – |
2004-02-02 |
4 |
A |
$21.45 |
$20,094 |
D/D |
937 |
937 |
|
- |
|
| DCTH |
Delcath Systems Inc |
Chief Executive Officer |
• • – |
2020-12-11 |
4 |
B |
$13.25 |
$99,375 |
D/D |
7,500 |
7,500 |
2.81 |
% |
|
| VCEL |
Vericel Corp |
CFO and VP, Corp. Development |
• – – |
2014-09-16 |
4 |
B |
$2.55 |
$51,000 |
D/D |
20,000 |
20,000 |
2.74 |
- |
|
| DCTH |
Delcath Systems Inc |
Chief Executive Officer |
• • – |
2021-06-25 |
4 |
B |
$11.35 |
$74,910 |
D/D |
6,600 |
29,600 |
2.81 |
% |
|
| ALBO |
Albireo Pharma Inc |
CFO, VP of Corp and Dev/Treas |
• – – |
2011-02-08 |
4 |
S |
$2.05 |
$8,200 |
D/D |
(4,000) |
31,125 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
CFO, VP of Corp and Dev/Treas |
• – – |
2011-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,600 |
35,125 |
0 |
- |
|
| DCTH |
Delcath Systems Inc |
Chief Executive Officer |
• • – |
2021-06-28 |
4 |
B |
$11.93 |
$74,563 |
D/D |
6,250 |
35,850 |
2.81 |
% |
|
| ALBO |
Albireo Pharma Inc |
CFO, VP of Corp and Dev/Treas |
• – – |
2012-09-30 |
4 |
D |
$2.87 |
$35,028 |
D/D |
(12,205) |
36,128 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
CFO, VP of Corp and Dev/Treas |
• – – |
2013-03-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,883) |
39,957 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
CFO, VP of Corp and Dev/Treas |
• – – |
2013-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,712 |
41,840 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
CFO, VP of Corp and Dev/Treas |
• – – |
2014-03-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,860) |
43,810 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
CFO, VP of Corp and Dev/Treas |
• – – |
2014-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,713 |
45,670 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
CFO, VP of Corp and Dev/Treas |
• – – |
2012-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,964 |
48,333 |
0 |
- |
|
| DCTH |
Delcath Systems Inc |
See Remarks |
• • – |
2021-12-02 |
4 |
B |
$8.61 |
$199,752 |
D/D |
23,200 |
59,050 |
2.81 |
% |
|
| DCTH |
Delcath Systems Inc |
See Remarks |
• • – |
2022-04-08 |
4 |
B |
$6.55 |
$13,136 |
D/D |
2,000 |
61,050 |
2.81 |
% |
|
| DCTH |
Delcath Systems Inc |
See Remarks |
• • – |
2022-04-18 |
4 |
B |
$6.34 |
$12,734 |
D/D |
2,000 |
63,050 |
2.81 |
% |
|
| VCEL |
Vericel Corp |
CFO and VP, Corp. Development |
• – – |
2019-03-11 |
4 |
AS |
$20.02 |
$200,235 |
D/D |
(10,000) |
122,249 |
0 |
- |
|
| VCEL |
Vericel Corp |
CFO and VP, Corp. Development |
• – – |
2019-04-08 |
4 |
AS |
$17.37 |
$275,592 |
D/D |
(15,625) |
122,672 |
0 |
- |
|
| VCEL |
Vericel Corp |
CFO and VP, Corp. Development |
• – – |
2019-05-13 |
4 |
AS |
$17.02 |
$297,859 |
D/D |
(17,500) |
122,672 |
0 |
- |
|
| VCEL |
Vericel Corp |
CFO and VP, Corp. Development |
• – – |
2019-06-10 |
4 |
AS |
$15.53 |
$273,373 |
D/D |
(17,500) |
122,672 |
0 |
- |
|
| VCEL |
Vericel Corp |
CFO and VP, Corp. Development |
• – – |
2019-07-15 |
4 |
AS |
$19.68 |
$334,579 |
D/D |
(17,000) |
123,182 |
0 |
- |
|
| VCEL |
Vericel Corp |
CFO and VP, Corp. Development |
• – – |
2019-08-14 |
4 |
AS |
$16.62 |
$282,547 |
D/D |
(17,000) |
123,182 |
0 |
- |
|
| VCEL |
Vericel Corp |
CFO and VP, Corp. Development |
• – – |
2019-04-08 |
4 |
OE |
$2.65 |
$50,375 |
D/D |
15,625 |
124,547 |
0 |
- |
|
| DCTH |
Delcath Systems Inc |
Chief Executive Officer |
• • – |
2022-07-20 |
4 |
B |
$3.98 |
$250,000 |
D/D |
62,814 |
125,864 |
2.81 |
% |
|
| VCEL |
Vericel Corp |
CFO and VP, Corp. Development |
• – – |
2019-02-11 |
4 |
AS |
$17.09 |
$170,880 |
D/D |
(10,000) |
132,249 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
